The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
87372482 8737248 2 F 2007 20160511 20120822 20160713 PER US-ASTRAZENECA-2010SE58972 ASTRAZENECA 71.00 YR M Y 90.70000 KG 20160713 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
87372482 8737248 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5, TWO PUFFS TWO TIMES A DAY 21929
87372482 8737248 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5, ONE PUFFS TWO TIMES A DAY 21929
87372482 8737248 3 SS TOPROL XL METOPROLOL SUCCINATE 1 Oral 0 50 MG MODIFIED-RELEASE TABLET QD
87372482 8737248 4 C TRAMADOL. TRAMADOL 1 Oral 0 50 MG Q8H
87372482 8737248 5 C TRAMADOL. TRAMADOL 1 Oral 50.0MG AS REQUIRED 0 50 MG
87372482 8737248 6 C AVAPRO IRBESARTAN 1 Oral 0 75 MG BID
87372482 8737248 7 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Oral 0 25 MG QD
87372482 8737248 8 C ASPIRIN. ASPIRIN 1 Oral 0 81 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
87372482 8737248 1 Chronic obstructive pulmonary disease
87372482 8737248 2 Chronic obstructive pulmonary disease
87372482 8737248 3 Blood pressure abnormal
87372482 8737248 4 Back pain
87372482 8737248 5 Back pain
87372482 8737248 6 Blood pressure abnormal
87372482 8737248 7 Joint swelling
87372482 8737248 8 Cardiac disorder

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
87372482 8737248 Abdominal distension
87372482 8737248 Amnesia
87372482 8737248 Arthralgia
87372482 8737248 Balance disorder
87372482 8737248 Blood pressure abnormal
87372482 8737248 Body height decreased
87372482 8737248 Condition aggravated
87372482 8737248 Dizziness
87372482 8737248 Emphysema
87372482 8737248 Extra dose administered
87372482 8737248 Gait disturbance
87372482 8737248 Headache
87372482 8737248 Heart valve incompetence
87372482 8737248 Hypertension
87372482 8737248 Hypotension
87372482 8737248 Impaired driving ability
87372482 8737248 Increased upper airway secretion
87372482 8737248 Middle insomnia
87372482 8737248 Muscle disorder
87372482 8737248 Muscle swelling
87372482 8737248 Muscular weakness
87372482 8737248 Osteoarthritis
87372482 8737248 Paraesthesia
87372482 8737248 Peripheral swelling
87372482 8737248 Product use issue
87372482 8737248 Rash generalised
87372482 8737248 Upper-airway cough syndrome
87372482 8737248 Vertigo
87372482 8737248 Visual field defect
87372482 8737248 Weight increased
87372482 8737248 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
87372482 8737248 1 2007 0
87372482 8737248 3 2004 0
87372482 8737248 6 2004 0
87372482 8737248 7 2013 0
87372482 8737248 8 2006 0